Radiation Therapy Approaches for People With Prostate Cancer
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.
Eligibility criteria
Qualifiers
Non-metastatic prostate cancer.
Classified as unfavorable intermediate-, high-, or very high-risk prostate cancer according to NCCN risk stratification guidelines. (Note: cT3a or T3b by MRI or PSMA PET allowed)
Considered by the treating radiation oncologist as a suitable candidate for both HDR brachytherapy boost and SBRT
Disqualifiers
None
Trial design
Treatments tested in this trial
- Standard of Care HDR Brachytherapy
- SBRT
Treatment groups
126 Participants
are divided into 2 treatment groupsSponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
Palette Life Sciences, Inc.
Collaborator
Source ClinicalTrials.gov